Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

REGENERATIVE MEDICINE - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Regenerative Medicine in US$ million.The report provides separate comprehensive analytics for the US, Japan, and Europe. Annual estimates and forecasts are provided for the period 2009 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 106 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Forticell Bioscience, Inc., Geron Corporation, Integra Orthobiologics, LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Tepha Inc., and TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1241
Price : $4500
Companies : 106
Pages : 381
Date : October 2010
Market Data Tables : 12

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  REGENERATIVE MEDICINE (Complete Report) Pages : 381   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......13 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
  
  2. INDUSTRY OVERVIEW........411 $950  
   Market Potential........4
Regenerative Medicine in Bone and Joint Applications........4
US Corners a Lion’s Share........4
Regenerative Medicine - the Past, the Present, & the Future........4
1$100
   Another Revolution in the Making?........51$100
   Conventional Chemical Medicine Vs Regenerative Medicine........6
The Need for Regenerative Medicine........6
1$100
   Regenerative Medicine Throws in Several New Therapies........7
What’s in Store?........7
Regenerative Medicine to Arrest Ageing........7
Thriving on an Aging World Population........7
1$100
   Faster Healing Process........8
Regenerative Medicine to Overcome Donor Organs Shortage........8
Possible Scenarios........8
1$100
   Stem Cell Research – Not Just Another Medical Advancement........9
Key Issues At Play........9
1$100
   Growth Drivers........10
Trends & Issues........10
Biomaterials Sought After in Regenerative Medicine........10
1$100
   Upbeat Market for Cell-based Tissue Engineering........11
Progenitor Cell Therapy to Witness No Holds Barred Growth........11
1$100
   Players Embrace Automation in Production Facilities........12
Contract Manufacturing, a Growing Sector........12
Investors Wary of Funding Regenerative Medicine........12
1$100
   Regenerative Medicine Field Lags Behind due to Segregated Focus........13
Challenges to Be Encountered by Tissue Engineering Companies........13
1$100
   Activity in the Field of Regenerative Medicine........14
1$100
  3. PRODUCT OVERVIEW........1510 $595  
   Regenerative Medicine Advances in Four Phases........15
Human Substances........15
Tissue Engineering........15
Therapeutic Cloning........15
Nanotechnology-Driven Biomaterials........15
1$100
   Types of Regenerative Medicine........16
Type I – Regenerative Medicine........16
Human Proteins and Genes are Drugs in Regenerative Medicine........16
1$100
   Type-2 Regenerative Medicine........17
Therapies Based on Human Cells and Tissues........17
1$100
   Type-3 Regenerative Medicine........18
Based on Embryonic Stem Cells........18
1$100
   The Opponents of the ESC Theory........19
Embryonic Stem Cells – Shortcomings........19
1$100
   Type-4 Regenerative Medicine........20
Based on Novel Materials / Material Science Advancements........20
1$100
   Overview of Major Regenerative Medicine Techniques........21
Natural Regenerative Proteins........21
1$100
   Tissue Engineering Capable of Culturing Replacement Organs........22
All About Stem Cells........22
1$100
   Adult Stem Cells........23
Adult Stem Cell Research Eludes Ethical Dispute........23
hESC – Highly Capable of Differentiating and Multiplying........23
Stem Cell Research in Development of Regenerative Medicine........23
1$100
   Neural Stem Cell to Restore Memory Functioning........24
Pancreatic Islet Cells to Control Blood Sugar in Diabetics........24
Therapeutic Cloning to Cure Parkinson’s........24
1$100
  4. REGULATORY ENVIRONMENT........25   
   Regulatory Norms Governing ES Cell Research........25
Milestones in the Human Embryonic Stem Cell Research: 2001........25
Legality of ES Cell Use in Major Developed Nations........25
1$100
  5. TECHNOLOGICAL INNOVATIONS / BREAKTHROUGHS........26   
   Kensey Nash’s Medeor ECM Receives Approval from US FDA........26
Celling Technologies Unveils Res-Q Device........26
Kinetic Wins FDA Approval for LifeCell Tissue Matrix........26
2$200
  6. TECHNOLOGICAL INNOVATIONS IN RECENT PAST – A PERSPECTIVE BUILDER........285 $395  
   Celprogen Launches 11 Cancer Stem Cells........28
Biovest International Launches AutovaxID™........28
Stelic Institute Announces New Treatment Method for Acute Liver Failure........28
1$100
   TissueGene Initiates Phase 1 Clinical Trials for TG-C........29
ISTO Announces FDA’s IND Approval for Neocartilage Graft........29
Cook Biotech Introduces Surgisis® AFP™ Anal Fistula Plug........29
1$100
   Korean Scientists Make a Major Breakthrough in Stem Cell Lines........30
Japanese Researchers Regenerate Jaw Bone........30
Geron Researchers Differentiate Hepatocytes from hESCs........30
1$100
   Geron Demonstrates Potential of hESCs in Treatment of Parkinson’s disease........31
Geron Researches Cardiomyocytes for Heart Disease........31
Endovasc Announces New Findings at Texas Heart Institute Research........31
1$100
   Geron and Celera Genomics Complete Characterization of Active Genes in hESCs........32
Rockefeller University Develops Solution for Maintaining Plupotency in hESCs........32
1$100
  7. RECENT INDUSTRY ACTIVITY........334 $295  
   Power3 Medical Inks Definitive Agreement to Acquire StemTroniX........33
Healthpoint Acquires CYZACTTM and ICX-SKN Technologies from Intercytex........33
Stem Cell Therapy International Merges with Histostem........33
TiGenix Acquires Orthomimetics........33
1$100
   Integra Inks Licensing Deal with Organogenesis........34
DePuy Spine Collaborates with ATRM........34
Epistem Enters into Partnership with Novartis........34
Athersys Inks Agreement with Pfizer........34
Beike Biotechnology Signs Investment Agreement with Biomaster........34
1$100
   Fujifilm Establishes New Drug Discovery Labs........35
KCI Acquires LifeCell........35
Organogenesis Takes Over NanoMatrix........35
Cytori and Green Hospital Supply Ink Strategic Equity Deal........35
1$100
   Sigma-Aldrich Signs Agreement with AlphaGenix........36
RNL Bio Establishes Research Unit at Newcastle University........36
Pfizer Establishes New Regenerative Medicine Research Unit........36
Tengion Begins Third Phase II Clinical Trial of Neo-Bladder Augment™........36
1$100
  8. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER........373 $295  
   Integra Life Sciences Acquires IsoTis, Inc.........37
Geron Increases Stake in TA Therapeutics........37
Organogenesis Signs MoU with NTEC........37
1$100
   BioTime Establishes New Stem Cell Division........38
NovaThera and Gamida Join Hands for Developing Cell Therapeutics for Lung
  Regeneration........38
Tigenix Teams Up With Fidea to Develop Biological Joint Implants........38
1$100
   Scotland Plans to Build Center for Regenerative Medicine in Edinburgh........39
1$100
  9. FOCUS ON SELECT GLOBAL PLAYERS........407 $595  
   BioVest International, Inc. (US)........40
Curis, Inc. (US)........40
1$100
   Cytori Therapeutics, Inc. (US)........41
DeveloGen AG (Germany)........41
1$100
   Forticell Bioscience, Inc. (US)........42
Geron Corporation (US)........42
1$100
   Integra Orthobiologics (US)........431$100
   LifeCell Corporation (US)........44
Osiris Therapeutics, Inc. (US)........44
1$100
   Tengion (US)........45
Tepha Inc. (US)........45
TiGenix N.V. (Belgium)........45
2$200
  10. GLOBAL MARKET PERSPECTIVE........47   
   Table 1: World Recent Past, Current & Future Market Analysis for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – US, Japan and Europe Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2015 (includes corresponding Graph/Chart)........471$350
   Table 2: World Historic Review for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – US, Japan, and Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)........481$350
   Table 3: World 11-Year Perspective for Regenerative Medicine Products for Bone and Joint Applications by Geographic Region – Percentage Breakdown of Dollar Sales for US, Japan and Europe for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........49
1$350
  11. THE UNITED STATES........508 $950  
   A. Market Analysis........50
Market Potential........50
Regenerative Medicine in Bone and Joint Applications........50
1$100
   Table 4: US Market for Regenerative Medicine Products for Bone and Joint Applications (2007, 2010 & 2013): Percentage Breakdown of Value Sales for Bone Replacement Grafting, Bone Growth Stimulators, and Tissue Engineering Cartilage (includes corresponding Graph/Chart)........51
Regenerative Therapy – Best Fit for Joint Problems........51
1$350
   Millions of American Patients Put their Hope in Stem Cell Research........52
Table 5: Prevalence of Various Diseases in the US (includes corresponding Graph/Chart)........52
US Witnesses Mixed Response for Government Support for hESC Research........52
1$350
   CBI’s Human Tissue Products for Treating Liver Failure and Diabetes........53
Market for Liver and Pancreas Transplantation........53
1$100
   Implantable Regenerative Products Take Over Sports Medicine........54
Key Players........54
Other Dominating Regional Players........54
3$300
   B. Market Analytics........57
Table 6: US Recent Past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications – Annual Sales Figures in US$ Million for Years 2009 through 2015 (includes corresponding Graph/Chart)........57

Table 7: US Historic Review for Regenerative Medicine Products for Bone and Joint Applications Market with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)........57
1$350
  12. JAPAN........584 $595  
   A. Market Analysis........58
Market Potential........58
Research Activity in Regenerative Medicine Field........58
More Companies Eye the Regenerative Medicine Potential........58
1$100
   Competition Heats up Behind Closed Doors........59
Japanese Firms Need to Catch Up with US and European Competitors........59
Science Ministry Rolls Out Regenerative Medicine Project........59
1$100
   Regenerative Medicine Exempted from Ban on Human Cloning........601$100
   B. Market Analytics........61
Table 8: Japanese Recent Past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2009 through 2015 (includes corresponding Graph/Chart)........61

Table 9: Japanese Historic Review for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)........61
1$350
  13. EUROPE........623 $595  
   A. Market Analysis........62
Oral Tissue Regeneration........62
Table 10: European Oral Tissue Regeneration Market (2009): Percentage Breakdown of Value Sales for Bone Graft Material, Membranes, and Tissue Regeneration (includes corresponding Graph/Chart)........62
Regional Overview........62
Germany........62
Key Players........62
1$350
   United Kingdom........63
Belgium........63
Select Player........63
1$100
   B. Market Analytics........64
Table 11: European Recent Past, Current & Future Analysis for Regenerative Medicine Products for Bone and Joint Applications with Annual Sales Figures in US$ Million for Years 2009 through 2015 (includes corresponding Graph/Chart)........64

Table 12: European Historic Review for Regenerative Medicine Products for Bone and Joint Applications Market with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)........64
1$350
  14. REVIEW OF REGENERATIVE MEDICINE IN OTHER GEOGRAPHIC MARKETS........65   
   Review of Regenerative Medicine in Other Geographic Markets........65
1$100
  14a. CANADA....65   
   University of Toronto – Spearheading Regenerative Medicine Research........65
1$100
  14b. ASIA-PACIFIC........653 $295  
   China........65
Substantial Government Support........65
1$100
   India........66
CSIR- Leading the way in Regenerative Medicine Research........66
High Growth Opportunities........66
Australia........66
Key Player........66
Stem Cell Sciences........66
1$100
   South Korea........67
Malaysia........67
Singapore........67
1$100
  14c. REST OF WORLD........68   
   Argentina........68
Israel........68
Select Major Players........68
Colbar R&D Ltd.........68
ProChon Biotech Ltd.........68
1$100
   South Africa........691$100
COMPETITION 306$995
  
Total Companies Profiled: 106 (including Divisions/Subsidiaries - 111)

Region/Country                 Players


The United States                 60    
Canada                             2
Japan                             12 
Europe                            20 
     Germany                       6
     The United Kingdom            6
     Italy                         1
     Rest of Europe                7
Asia-Pacific (Excluding Japan)     9
Latin America                      1
Africa                             4
Middle-East                        3
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign